In the BioHarmony Drug Report Database

"Preview" Icon

Atracurium

Tracrium (atracurium) is a small molecule pharmaceutical. Atracurium was first approved as Tracrium on 1983-11-23. It is known to target neuronal acetylcholine receptor subunit alpha-4, neuronal acetylcholine receptor subunit alpha-7, acetylcholine receptor subunit alpha, and neuronal acetylcholine receptor subunit alpha-3.

 

Trade Name

 

Tracrium
 

Common Name

 

atracurium
 

ChEMBL ID

 

CHEMBL1360
 

Indication

 

 

Drug Class

 

Quaternary ammonium derivatives: neuromuscular blocking agents

Image (chem structure or protein)

Atracurium structure rendering